Literature DB >> 26156617

Endoscopic and oncologic outcomes according to indication criteria of endoscopic resection for early gastric cancer: a systematic review and meta-analysis.

Se Woo Park1, Hyuk Lee2, Chan Hyuk Park3, Hyun Joo Jang4, Hongyup Ahn5.   

Abstract

BACKGROUND: The criteria for endoscopic resection for early gastric cancer (EGC) have been expanded recently, and it has become acceptable to use techniques that are regarded as having equivalent technical and pathological outcomes to absolute indication (AI). However, the long-term oncological outcomes of expanded indication (EI) have yet to be clarified. This meta-analysis aimed to assess the long-term outcome of EI versus AI, to identify the endoscopic feasibility and safety according to the indication, and to provide the appropriate recommendations for each indication.
METHODS: Electronic databases including PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and KoreaMed were searched for articles published between January 2000 and October 2014. After screening, the reviewers extracted the information from 12 retrospective cohort studies. A total of 9635 EGC lesions, 4150 lesions in the EI group and 5485 lesions in the AI group, were included in this study.
RESULTS: Meta-analyses showed that the local recurrence rate [risk ratio (RR) 1.34; 95% CI 0.67-2.70] was not significantly higher in the EI group compared with the AI group, although the metachronous recurrence rate was higher in the EI group than in the AI group (RR 1.60; 95% CI 1.22-2.10). The rates of en bloc resection [odds ratio (OR) 0.57; 95% CI 0.41-0.78), complete resection (OR 0.37; 95% CI 0.25-0.57), and curative resection (OR 0.34; 95% CI 0.20-0.58) were significantly inferior in the EI group than in the AI group, whereas overall bleeding risk (RR 1.47; 95% CI 1.19-1.82) and procedure-related perforation rate (OR 2.04; 95% CI 1.56-2.68) were significantly higher in the EI group than in the AI group.
CONCLUSIONS: This meta-analysis suggests that the EI group showed acceptable long-term outcomes with local recurrence rate that was not significantly inferior, although the metachronous recurrence rate was higher compared with that in the AI group.

Entities:  

Keywords:  Early gastric cancer; Endoscopic resection; Indication; Meta-analysis; Systematic review

Mesh:

Year:  2015        PMID: 26156617     DOI: 10.1007/s00464-015-4376-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  39 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Long-term clinical outcomes of endoscopic resection for early gastric cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; Y Kato; M Stolte
Journal:  J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 4.029

Review 5.  Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract.

Authors:  Roy Soetikno; Tonya Kaltenbach; Ronald Yeh; Takuji Gotoda
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

6.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Authors:  Shiro Oka; Shinji Tanaka; Iwao Kaneko; Ritsuo Mouri; Mayuko Hirata; Toru Kawamura; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

7.  Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery.

Authors:  Do-Joong Park; Hyeon-Kook Lee; Hyuk-Joon Lee; Hye-Seung Lee; Woo-Ho Kim; Han-Kwang Yang; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

8.  Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.

Authors:  Hyun Jeong Kang; Dae Hwan Kim; Tae-Yong Jeon; Soo-Han Lee; Nari Shin; Sue-Hye Chae; Gwang Ha Kim; Geum Am Song; Dong-Heon Kim; Amitabh Srivastava; Do Youn Park; Gregory Y Lauwers
Journal:  Gastrointest Endosc       Date:  2010-06-15       Impact factor: 9.427

9.  Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study.

Authors:  H Isomoto; S Shikuwa; N Yamaguchi; E Fukuda; K Ikeda; H Nishiyama; K Ohnita; Y Mizuta; J Shiozawa; S Kohno
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

10.  Clinical outcomes of the endoscopic submucosal dissection of early gastric cancer are comparable between absolute and new expanded criteria.

Authors:  Keun Young Shin; Seong Woo Jeon; Kwang Bum Cho; Kyung Sik Park; Eun Soo Kim; Chang Keun Park; Yun Jin Chung; Joong Goo Kwon; Jin Tae Jung; Eun Young Kim; Kyeong Ok Kim; Byung Ik Jang; Si Hyung Lee; Jeong Bae Park; Chang Hun Yang
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

View more
  2 in total

1.  Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis.

Authors:  Jun Chul Park; Yong Kang Lee; Soon Young Kim; Yunho Roh; Kyu Yeon Hahn; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Hyoung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh
Journal:  Surg Endosc       Date:  2017-10-19       Impact factor: 4.584

2.  Efficacy of submucosal bupivacaine injection for pain relief after endoscopic submucosal dissection: A multicenter, prospective, randomized controlled, and double-blind trial.

Authors:  Jang Han Jung; Hyun Joo Jang; Chang Seok Bang; Gwang Ho Baik; Se Woo Park
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.